Depressive disorders.
D000588:Amines / Q000378:metabolism; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001569:Benzodiazepines; D001835:Body Weight; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D004565:Electroconvulsive Therapy; D004967:Estrogens / Q000097:blood; D005260:Female; D006760:Hospitalization; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D008598:Menstruation; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009638:Norepinephrine / Q000172:deficiency; D010817:Physician-Patient Relations; D012701:Serotonin / Q000172:deficiency; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology; D012964:Sodium / Q000378:metabolism; D013390:Succinylcholine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000588:Amines; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D004967:Estrogens; D006993:Hypnotics and Sedatives; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D001569:Benzodiazepines; D012701:Serotonin; D008094:Lithium; D012964:Sodium; D013390:Succinylcholine; D006854:Hydrocortisone; D009638:Norepinephrine